P355 Long-term impact of elexacaftor/tezacaftor/ivacaftor (ETI) therapy on weight gain and body composition in adult cystic fibrosis patients: a retrospective analysis.

Autor: Šmuljić, Z.1,2 (AUTHOR), Baretić, M.1,3,4 (AUTHOR), Vukić Dugac, A.1,4,5 (AUTHOR), Odobašić Palković, T.1,5 (AUTHOR), Kirigin Biloš, L.6 (AUTHOR), Bambir, I.1,7 (AUTHOR), Tješić-Drinković, D.1,4,7 (AUTHOR)
Zdroj: Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS177-S177. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: